Preserving Pregnancy in Face of Cervical Cancer: Favorable Fetal and Maternal Outcomes – An Evidence Based Case Report

Authors

  • Rima Irwinda Fetomaternal Division, Departement of Obstetrics and Gynecology, Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesiaa
  • Lisa Novianti Department of Obstetrics and Gynecology, Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia https://orcid.org/0009-0007-5156-8412
  • M Adya F Dilmy Department of OFetomaternal Division, Departement of Obstetrics and Gynecology, Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesiabstetrics and Gynecology Faculty of Medicine Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital, Jakarta
  • Hariyono Winarto Oncology Division, Departement of Obstetrics and Gynecology, Faculty of Medicine, University of Indonesia, Cipto Mangunkusumo Hospital, Jakarta, Indonesia

DOI:

https://doi.org/10.25077/aoj.10.2.194-217.2026

Keywords:

pregnancy, cervical cancer, favorable fetal, maternal outcome

Abstract

Background: Cervical cancer diagnosed during pregnancy poses a complex clinical and ethical dilemma, requiring a balance between timely maternal cancer treatment and fetal preservation. Recent studies show that pregnancy itself does not worsen long-term cancer outcomes, allowing for a more individualized approach especially in early-stage disease, where delaying treatment until fetal viability can be both safe and practical

 

Purpose: This evidence-based review aimed to summarize current evidence on the safety and outcomes of conservative management for early-stage cervical cancer during pregnancy

 

Methods: We explored journal databases (PubMed, Cochrane, and Google Scholar). We included meta-analyses, systematic reviews, or observational studies published in English

 

Results: We found three studies that fulfilled our inclusion criteria; they were two meta-analyses and one retrospective cohort study. Zuoxi et al concluded that there was no survival difference between the 2 groups (100% vs. 90.91%, P=0.54), and none of the pregnant women who died had delayed treatment due to pregnancy. Zeng et al, the primary outcome of interest is long-term survival, as pregnancy termination and timing of delivery did not significantly affect the 5-year OS (P > 0.05).

 

Conclusion: This evidence-based case report underscores the feasibility and clinical efficacy of a conservative, individualized management strategy for patients diagnosed with early-stage cervical cancer during pregnancy, where a comprehensive understanding of current evidence empowers clinicians and patients to collaborate on treatment plan that addresses both maternal survival and fetal well-being.

References

1. Morice P, Uzan C, Gouy S, Verschraegen C, Haie-Meder C. Gynaecological cancers in pregnancy. Lancet [Internet]. 2012;379(9815):558–69. Available from: https://dx.doi.org/10.1016/S0140-6736(11)60829-5

2. Bigelow CA, Horowitz NS, Goodman A, Growdon WB, Del Carmen M, Kaimal AJ. Management and outcome of cervical cancer diagnosed in pregnancy. Am J Obstet Gynecol. 2017;216(3):276.e1-276.e6.

3. Wahidin M, Febrianti R, Susanty F. Burden of cervical cancer in Indonesia: Findings from the global burden of disease study 1990–2017 [Internet]. Atlantis Press, 2020 [cited 2024 May 16]; p. 213–217.Available from: https://www.atlantis-press.com/procee.

4. Amant F, Berveiller P, Boere IA, Cardonick E, Fruscio R, Fumagalli M, et al. Gynecologic cancers in pregnancy: Guidelines based on a third international consensus meeting. Ann Oncol. 2019;30(10):1601–12.

5. Cibula D, Raspollini MR, Planchamp F, Centeno C, Chargari C, Felix A, et al. ESGO/ESTRO/ESP Guidelines for the management of patients with cervical cancer - Update 2023. Int J Gynecol Cancer [Internet]. 2023;33(5):649–66. Available from: https://doi.org/10.1136/ijgc-2023-004429

6. Sonoda K, Ohgami T, Hachisuga M, Fujita Y, Okugawa K, Yahata H, et al. Difficulty of cervical cancer diagnosis during pregnancy: A case series analysis of the clinicopathological characteristics and prognosis of cervical cancer diagnosed during pregnancy or within 6 months after parturition. Mol Clin Oncol. 2021;14(4):1–7.

7. Bernardini F, Ferrandina G, Ricci C, Fagotti A, Fanfani F, Cavaliere AF, et al. Neoadjuvant Chemotherapy in Pregnant Patients with Cervical Cancer: A Monocentric Retrospective Study. Curr Oncol. 2022;29(8):5702–14.

8. He Z, Xie C, Qi X, Hu Z, He Y. The effect of preserving pregnancy in cervical cancer diagnosed during pregnancy: a retrospective study. BMC Womens Health [Internet]. 2022;22(1):1–8. Available from: https://doi.org/10.1186/s12905-022-01885-w

9. Zeng S, Li X, Xiao S, Yang P, Lin C, Chen H, et al. Prognostic evaluation and treatment strategies for cervical cancer in pregnancy: a systematic review and meta-analysis. BMC Cancer. 2025;25(1).

Downloads

Published

2026-08-13

How to Cite

Irwinda, R., Novianti, L., Dilmy, M. A. F., & Winarto, H. (2026). Preserving Pregnancy in Face of Cervical Cancer: Favorable Fetal and Maternal Outcomes – An Evidence Based Case Report. Andalas Obstetrics And Gynecology Journal, 10(2), 194–217. https://doi.org/10.25077/aoj.10.2.194-217.2026

Issue

Section

LITERATURE REVIEW